Early-access program: novel VLP extraction control

Get a sneak peek into our new product in development.

At Takara Bio, we innovate continuously to provide you with the best solutions to enable and facilitate your workflows.

We have developed a high-quality RNA-encapsulation method that yields exceptionally stable but noncontagious virus-like particles (VLPs). These VLPs encapsulate a unique exogenous sequence with no known homology to any nucleotide sequence, making them the ideal spike-in control for molecular testing workflows. Our novel VLP control is:

Accurate—biomimetic control with precise RNA copy number
Stable—temperature and RNase resistant
Automatable—easy integration into extraction and RT-qPCR workflows

Be the first to unlock the future! Sign up below and get a glimpse into what’s coming.

Sign up for early access

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.